NYSE: MRK
Merck & Co., Inc.
$146.94▼ -2.27%Thursday, Nov 5 close · data delayed
Past 90 trading days
- 30-day change
- ▲ +0.92%
- 90-day high
- $156.45
- 90-day low
- $120.78
- Avg volume (20d)
- 10.6M
- Market cap
- $362.0B
- 52-week high
- $156.92
- 52-week low
- $73.31
Bellwize coverage
Stocks
Merck Surges 12.6% After Its Cancer Vaccine With Moderna Clears a Phase 3 TrialMerck jumped to the top of its three-month range after a late-stage melanoma study of its personalized mRNA vaccine met its main goal.
Aug 20, 2026, 9:16 AM ET
Company resources
This is a general-market summary for information only — not investment advice, and not a recommendation regarding any security.